Design, Synthesis and Antimicrobial Properties of New Tetracyclic Quinobenzothiazine Derivatives.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Dec 2022
Historique:
received: 04 11 2022
revised: 28 11 2022
accepted: 28 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

A new method for modifying the structure of tetracyclic quinobenzothiazinium derivatives has been developed, allowing introduction of various substituents at different positions of the benzene ring. The method consists of reacting appropriate aniline derivatives with 5,12-(dimethyl)thioquinantrenediinium bis-chloride. A series of new quinobenzothiazine derivatives was obtained with propyl, allyl, propargyl and benzyl substituents in 9, 10 and 11 positions, respectively. The structure of the obtained compounds was analyzed by 1H and 13C NMR (HSQC, HMBC) and X-ray analysis. All the compounds were tested against reference strains Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212, and representatives of multidrug-resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecalis (VRE). In addition, all the compounds were evaluated in vitro against Mycobacterium smegmatis ATCC 700084 and M. marinum CAMP 5644. 9-Benzyloxy-5-methyl-12H-quino [3,4-b][1,4]benzothiazinium chloride (6j), 9-propoxy-5-methyl-12H-quino[3,4-b][1,4]benzothiazinium chloride (6a) and 9-allyloxy-5-methyl-12H-quino[3,4-b][1,4]benzothiazinium chloride (6d) demonstrated high activity against the entire tested microbial spectrum. The activities of the compounds were comparable with oxacillin, tetracycline and ciprofloxacinagainst staphylococcal strains and with rifampicin against both mycobacterial strains. Compound 6j had a significant effect on the inhibition of bacterial respiration as demonstrated by the MTT assay. The compounds showed not only bacteriostatic activity, but also bactericidal activity. Preliminary in vitro cytotoxicity screening of the compounds performed using normal human dermal fibroblasts (NHDF) proved that the tested compounds showed an insignificant cytotoxic effect on human cells (IC50 > 37 µM), making these compounds interesting for further investigation. Moreover, the intermolecular similarity of novel compounds was analyzed in the multidimensional space (mDS) of the structure/property-related in silico descriptors by means of principal component analysis (PCA) and hierarchical clustering analysis (HCA), respectively. The distance-oriented structure/property distribution was related with the experimental lipophilic data.

Identifiants

pubmed: 36499402
pii: ijms232315078
doi: 10.3390/ijms232315078
pmc: PMC9736374
pii:
doi:

Substances chimiques

Chlorides 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical University of Silesia
ID : PCN-1-039/K/2/F
Organisme : Medical University of Silesia
ID : PCN-2-006/N/1/F
Organisme : Medical University of Silesia
ID : PCN-1-060/K/0/F

Références

Infect Disord Drug Targets. 2013 Apr;13(2):85-115
pubmed: 23808874
Chem Pharm Bull (Tokyo). 2002 Jul;50(7):922-9
pubmed: 12130850
Drug Discov Today. 2022 Jul;27(7):2028-2041
pubmed: 35561965
Eur J Med Chem. 2011 Aug;46(8):3179-89
pubmed: 21620536
J Antimicrob Chemother. 2013 Apr;68(4):869-80
pubmed: 23228936
Molecules. 2015 May 27;20(6):9767-87
pubmed: 26023938
J Chem Inf Comput Sci. 2003 May-Jun;43(3):819-28
pubmed: 12767139
Bioorg Med Chem. 2013 Nov 1;21(21):6574-81
pubmed: 24045008
Tuberculosis (Edinb). 2013 Jul;93(4):398-400
pubmed: 23647650
Expert Opin Drug Discov. 2022 Sep;17(9):949-968
pubmed: 35787715
Acta Histochem. 2018 May;120(4):303-311
pubmed: 29606555
Chem Pharm Bull (Tokyo). 2004 Jun;52(6):675-87
pubmed: 15187387
J Chem Inf Model. 2007 Jul-Aug;47(4):1469-80
pubmed: 17567123
Am J Ther. 2006 May-Jun;13(3):261-73
pubmed: 16772768
Int J Mol Sci. 2022 Oct 01;23(19):
pubmed: 36232947
Future Med Chem. 2009 Jun;1(3):451-66
pubmed: 21426126
PLoS Pathog. 2010 Apr 08;6(4):e1000855
pubmed: 20386717
Int J Antimicrob Agents. 2013 Jan;41(1):41-6
pubmed: 23141113
Molecules. 2011 Mar 14;16(3):2414-30
pubmed: 21403599
Molecules. 2016 Nov 04;21(11):
pubmed: 27827930
Molecules. 2019 Jul 05;24(13):
pubmed: 31284397
Acta Biochim Pol. 2011;58(4):433-48
pubmed: 22187677
Biomed Res Int. 2015;2015:349534
pubmed: 25692135
Acta Crystallogr A Found Adv. 2015 Jan;71(Pt 1):3-8
pubmed: 25537383
Microorganisms. 2020 Jul 25;8(8):
pubmed: 32722391
Molecules. 2018 Dec 11;23(12):
pubmed: 30544967
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
J Med Chem. 2014 Mar 27;57(6):2568-81
pubmed: 24568631
Environ Microbiol. 2014 Apr;16(4):939-49
pubmed: 23919480
Clin Infect Dis. 2004 Mar 15;38(6):864-70
pubmed: 14999632
Eur J Med Chem. 2010 Dec;45(12):6152-8
pubmed: 20926162
Eur J Med Chem. 2017 Sep 29;138:774-806
pubmed: 28734245
Eur J Med Chem. 2010 Nov;45(11):4733-9
pubmed: 20813435
Eur J Med Chem. 2009 Mar;44(3):1303-10
pubmed: 18835067
Pharmacol Rep. 2012;64(1):16-23
pubmed: 22580516
Int J Mol Sci. 2021 Mar 26;22(7):
pubmed: 33810550
Bioorg Med Chem. 2015 Aug 1;23(15):4188-4196
pubmed: 26183541
J Nat Prod. 1982 Jan-Feb;45(1):1-14
pubmed: 7069421
Acta Pol Pharm. 2012 Nov-Dec;69(6):1149-52
pubmed: 23285676
J Bacteriol. 2014 Jun;196(11):2012-22
pubmed: 24659768
mBio. 2020 Nov 24;11(6):
pubmed: 33234689
Int Microbiol. 2015 Mar;18(1):1-12
pubmed: 26415662
J Infect Public Health. 2020 Sep;13(9):1255-1264
pubmed: 32674978
Med Chem Res. 2013 Sep;22(9):4158-4163
pubmed: 23914127
Int J Mol Sci. 2021 Nov 26;22(23):
pubmed: 34884631
J Vis Exp. 2018 Oct 8;(140):
pubmed: 30346391
Front Microbiol. 2016 May 23;7:760
pubmed: 27242772
Molecules. 2016 Aug 16;21(8):
pubmed: 27537867

Auteurs

Ewa Kisiel-Nawrot (E)

Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Dominika Pindjakova (D)

Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia.

Malgorzata Latocha (M)

Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 9, 41-200 Sosnowiec, Poland.

Andrzej Bak (A)

Institute of Chemistry, University of Silesia, Szkolna 9, 40-007 Katowice, Poland.

Violetta Kozik (V)

Institute of Chemistry, University of Silesia, Szkolna 9, 40-007 Katowice, Poland.

Kinga Suwinska (K)

Faculty of Mathematics and Natural Sciences, Cardinal Stefan Wyszyński University, K. Woycickiego 1/3, 01-938 Warszawa, Poland.

Aleksander Sochanik (A)

Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Wybrzeże AK 15, 44-101 Gliwice, Poland.

Alois Cizek (A)

Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic.

Josef Jampilek (J)

Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovicova 6, 842 15 Bratislava, Slovakia.
Department of Chemical Biology, Faculty of Science, Palacky University Olomouc, Slechtitelu 27, 783 71 Olomouc, Czech Republic.

Andrzej Zięba (A)

Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH